Federal task force seeks standards for immunotherapy biomarker studies.
Joel B
JB
Finkelstein
D026683:Advisory Committees; D015415:Biomarkers / Q000032:analysis*; D002986:Clinical Trials as Topic; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008495:Medical Oncology / Q000592:standards* / Q000639:trends; D009369:Neoplasms / Q000628:therapy*; D012107:Research Design; D014481:United States
D015415:Biomarkers